| UniProt ID | REST_HUMAN | |
|---|---|---|
| UniProt AC | Q13127 | |
| Protein Name | RE1-silencing transcription factor | |
| Gene Name | REST | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1097 | |
| Subcellular Localization | Nucleus . Colocalizes with ZFP90 in the nucleus. | |
| Protein Description | Transcriptional repressor which binds neuron-restrictive silencer element (NRSE) and represses neuronal gene transcription in non-neuronal cells. Restricts the expression of neuronal genes by associating with two distinct corepressors, mSin3 and CoREST, which in turn recruit histone deacetylase to the promoters of REST-regulated genes. Mediates repression by recruiting the BHC complex at RE1/NRSE sites which acts by deacetylating and demethylating specific sites on histones, thereby acting as a chromatin modifier. Transcriptional repression by REST-CDYL via the recruitment of histone methyltransferase EHMT2 may be important in transformation suppression.. | |
| Protein Sequence | MATQVMGQSSGGGGLFTSSGNIGMALPNDMYDLHDLSKAELAAPQLIMLANVALTGEVNGSCCDYLVGEERQMAELMPVGDNNFSDSEEGEGLEESADIKGEPHGLENMELRSLELSVVEPQPVFEASGAPDIYSSNKDLPPETPGAEDKGKSSKTKPFRCKPCQYEAESEEQFVHHIRVHSAKKFFVEESAEKQAKARESGSSTAEEGDFSKGPIRCDRCGYNTNRYDHYTAHLKHHTRAGDNERVYKCIICTYTTVSEYHWRKHLRNHFPRKVYTCGKCNYFSDRKNNYVQHVRTHTGERPYKCELCPYSSSQKTHLTRHMRTHSGEKPFKCDQCSYVASNQHEVTRHARQVHNGPKPLNCPHCDYKTADRSNFKKHVELHVNPRQFNCPVCDYAASKKCNLQYHFKSKHPTCPNKTMDVSKVKLKKTKKREADLPDNITNEKTEIEQTKIKGDVAGKKNEKSVKAEKRDVSKEKKPSNNVSVIQVTTRTRKSVTEVKEMDVHTGSNSEKFSKTKKSKRKLEVDSHSLHGPVNDEESSTKKKKKVESKSKNNSQEVPKGDSKVEENKKQNTCMKKSTKKKTLKNKSSKKSSKPPQKEPVEKGSAQMDPPQMGPAPTEAVQKGPVQVEPPPPMEHAQMEGAQIRPAPDEPVQMEVVQEGPAQKELLPPVEPAQMVGAQIVLAHMELPPPMETAQTEVAQMGPAPMEPAQMEVAQVESAPMQVVQKEPVQMELSPPMEVVQKEPVQIELSPPMEVVQKEPVKIELSPPIEVVQKEPVQMELSPPMGVVQKEPAQREPPPPREPPLHMEPISKKPPLRKDKKEKSNMQSERARKEQVLIEVGLVPVKDSWLLKESVSTEDLSPPSPPLPKENLREEASGDQKLLNTGEGNKEAPLQKVGAEEADESLPGLAANINESTHISSSGQNLNTPEGETLNGKHQTDSIVCEMKMDTDQNTRENLTGINSTVEEPVSPMLPPSAVEEREAVSKTALASPPATMAANESQEIDEDEGIHSHEGSDLSDNMSEGSDDSGLHGARPVPQESSRKNAKEALAVKAAKGDFVCIFCDRSFRKGKDYSKHLNRHLVNVYYLEEAAQGQE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 85 | Phosphorylation | PVGDNNFSDSEEGEG CCCCCCCCCCCCCCC | 42.21 | 23090842 | |
| 87 | Phosphorylation | GDNNFSDSEEGEGLE CCCCCCCCCCCCCCH | 36.03 | 23090842 | |
| 96 | Phosphorylation | EGEGLEESADIKGEP CCCCCHHHCCCCCCC | 23.13 | 23090842 | |
| 201 | Phosphorylation | KQAKARESGSSTAEE HHHHHHHHCCCCCCC | 38.12 | 28102081 | |
| 203 | Phosphorylation | AKARESGSSTAEEGD HHHHHHCCCCCCCCC | 33.52 | 28102081 | |
| 204 | Phosphorylation | KARESGSSTAEEGDF HHHHHCCCCCCCCCC | 34.85 | 28102081 | |
| 205 | Phosphorylation | ARESGSSTAEEGDFS HHHHCCCCCCCCCCC | 39.52 | 25627689 | |
| 212 | Phosphorylation | TAEEGDFSKGPIRCD CCCCCCCCCCCEECC | 41.25 | - | |
| 280 | Ubiquitination | RKVYTCGKCNYFSDR CCEEEECCCCCCCCC | 22.81 | - | |
| 325 (in isoform 3) | Phosphorylation | - | 16.90 | 22210691 | |
| 327 (in isoform 3) | Phosphorylation | - | 48.29 | 22210691 | |
| 442 | Phosphorylation | ADLPDNITNEKTEIE CCCCCCCCCCCHHHH | 43.51 | 22167270 | |
| 495 | Phosphorylation | VTTRTRKSVTEVKEM EEECCCCCCEEEEEE | 30.86 | - | |
| 500 | Acetylation | RKSVTEVKEMDVHTG CCCCEEEEEEEECCC | 40.88 | 20167786 | |
| 510 | Phosphorylation | DVHTGSNSEKFSKTK EECCCCCCHHCCCCH | 43.81 | 24719451 | |
| 512 | Acetylation | HTGSNSEKFSKTKKS CCCCCCHHCCCCHHC | 55.55 | 20167786 | |
| 527 | Phosphorylation | KRKLEVDSHSLHGPV CCCEEECCCCCCCCC | 21.83 | 20873877 | |
| 529 | Phosphorylation | KLEVDSHSLHGPVND CEEECCCCCCCCCCC | 26.47 | 25849741 | |
| 545 | Acetylation | ESSTKKKKKVESKSK CCCCHHHHHHCCCCC | 71.57 | 19820943 | |
| 546 | Acetylation | SSTKKKKKVESKSKN CCCHHHHHHCCCCCC | 61.18 | 19820953 | |
| 549 | Phosphorylation | KKKKKVESKSKNNSQ HHHHHHCCCCCCCCC | 45.26 | 26074081 | |
| 551 | Phosphorylation | KKKVESKSKNNSQEV HHHHCCCCCCCCCCC | 50.31 | 26074081 | |
| 552 | Acetylation | KKVESKSKNNSQEVP HHHCCCCCCCCCCCC | 64.98 | 19820959 | |
| 555 | Phosphorylation | ESKSKNNSQEVPKGD CCCCCCCCCCCCCCC | 36.79 | 26074081 | |
| 563 | Phosphorylation | QEVPKGDSKVEENKK CCCCCCCCHHHHHHH | 47.47 | 26074081 | |
| 569 | Acetylation | DSKVEENKKQNTCMK CCHHHHHHHHCCCCC | 60.04 | 19815497 | |
| 570 | Acetylation | SKVEENKKQNTCMKK CHHHHHHHHCCCCCH | 61.43 | 19815503 | |
| 573 | Phosphorylation | EENKKQNTCMKKSTK HHHHHHCCCCCHHHC | 16.10 | 26074081 | |
| 576 | Acetylation | KKQNTCMKKSTKKKT HHHCCCCCHHHCHHH | 45.80 | 19815513 | |
| 578 | Phosphorylation | QNTCMKKSTKKKTLK HCCCCCHHHCHHHHC | 39.68 | 26670566 | |
| 579 | Phosphorylation | NTCMKKSTKKKTLKN CCCCCHHHCHHHHCC | 56.62 | 26670566 | |
| 582 | Ubiquitination | MKKSTKKKTLKNKSS CCHHHCHHHHCCCCC | 61.72 | - | |
| 587 | Ubiquitination | KKKTLKNKSSKKSSK CHHHHCCCCCCCCCC | 55.29 | - | |
| 588 | Phosphorylation | KKTLKNKSSKKSSKP HHHHCCCCCCCCCCC | 57.70 | 21712546 | |
| 589 | Phosphorylation | KTLKNKSSKKSSKPP HHHCCCCCCCCCCCC | 45.79 | 21712546 | |
| 592 | Phosphorylation | KNKSSKKSSKPPQKE CCCCCCCCCCCCCCC | 47.53 | 21712546 | |
| 734 | Phosphorylation | EPVQMELSPPMEVVQ CCCCCCCCCCCEEEE | 17.41 | 30576142 | |
| 750 | Phosphorylation | EPVQIELSPPMEVVQ CCEEEEECCCCCEEE | 17.73 | 25159151 | |
| 766 | Phosphorylation | EPVKIELSPPIEVVQ CCEEEEECCCEEEEE | 18.81 | 30266825 | |
| 782 | Phosphorylation | EPVQMELSPPMGVVQ CCEEEECCCCCCCCC | 17.41 | 28348404 | |
| 854 | Phosphorylation | DSWLLKESVSTEDLS CCEEECCCCCCCCCC | 21.56 | 28176443 | |
| 856 | Phosphorylation | WLLKESVSTEDLSPP EEECCCCCCCCCCCC | 35.04 | 23403867 | |
| 857 | Phosphorylation | LLKESVSTEDLSPPS EECCCCCCCCCCCCC | 31.22 | 23403867 | |
| 861 | Phosphorylation | SVSTEDLSPPSPPLP CCCCCCCCCCCCCCC | 47.27 | 30266825 | |
| 864 | Phosphorylation | TEDLSPPSPPLPKEN CCCCCCCCCCCCHHH | 42.40 | 29255136 | |
| 940 | Phosphorylation | TLNGKHQTDSIVCEM CCCCCCCCCCEEEEE | 31.28 | 20068231 | |
| 942 | Phosphorylation | NGKHQTDSIVCEMKM CCCCCCCCEEEEEEC | 21.95 | 20068231 | |
| 960 | Phosphorylation | QNTRENLTGINSTVE CCHHHHCCCCCCCCC | 47.82 | 30624053 | |
| 971 | Phosphorylation | STVEEPVSPMLPPSA CCCCCCCCCCCCHHH | 18.46 | 30624053 | |
| 986 | Phosphorylation | VEEREAVSKTALASP HHHHHHHHHHHHCCC | 31.19 | - | |
| 1024 | Phosphorylation | SDLSDNMSEGSDDSG CCCCCCCCCCCCCCC | 45.09 | - | |
| 1027 | Phosphorylation | SDNMSEGSDDSGLHG CCCCCCCCCCCCCCC | 33.91 | - | |
| 1030 | Phosphorylation | MSEGSDDSGLHGARP CCCCCCCCCCCCCCC | 48.52 | - | |
| 1048 | Ubiquitination | ESSRKNAKEALAVKA HHHHCCHHHHHHHHH | 53.57 | - | |
| 1054 | Ubiquitination | AKEALAVKAAKGDFV HHHHHHHHHHCCCEE | 36.70 | - | |
| 1057 | Ubiquitination | ALAVKAAKGDFVCIF HHHHHHHCCCEEEEE | 64.96 | - | |
| 1077 | Ubiquitination | RKGKDYSKHLNRHLV HCCCCHHHHHHHHHE | 45.97 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 861 | S | Phosphorylation | Kinase | ERK2 | P28482 | PSP |
| 861 | S | Phosphorylation | Kinase | ERK1 | P27361 | PSP |
| 864 | S | Phosphorylation | Kinase | ERK2 | P28482 | PSP |
| 864 | S | Phosphorylation | Kinase | ERK1 | P27361 | PSP |
| 1030 | S | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
| - | K | Ubiquitination | E3 ubiquitin ligase | FBXW11 | Q9UKB1 | PMID:24658274 |
| - | K | Ubiquitination | E3 ubiquitin ligase | BTRC | Q9Y297 | PMID:14523018 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of REST_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of REST_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-864, AND MASSSPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-864, AND MASSSPECTROMETRY. | |